01110.HK

Aug 27, 2026, 16:27 UTC

Kingworld Medicines Group announced its interim results for the six months ended June 30, 2026, with revenue of 275 million RMB, down 32% year-on-year, net loss narrowing from 5.41 million RMB in the prior-year period to 5.22 million RMB, loss per share of 0.9 cents, and no dividend.